NDC 25021-414

Argatroban

Argatroban

Argatroban is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is Argatroban.

Product ID25021-414_ad621983-1701-4abe-9623-815387837fa8
NDC25021-414
Product TypeHuman Prescription Drug
Proprietary NameArgatroban
Generic NameArgatroban
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2021-04-15
Marketing CategoryANDA /
Application NumberANDA214235
Labeler NameSagent Pharmaceuticals
Substance NameARGATROBAN
Active Ingredient Strength1 mg/mL
Pharm ClassesAnti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 25021-414-50

1 VIAL in 1 CARTON (25021-414-50) > 50 mL in 1 VIAL
Marketing Start Date2021-04-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Argatroban" or generic name "Argatroban"

NDCBrand NameGeneric Name
0078-0930ARGATROBANargatroban
0143-9288ArgatrobanArgatroban
0143-9377ArgatrobanArgatroban
0143-9559ArgatrobanArgatroban
0143-9674ArgatrobanArgatroban
0409-1140ArgatrobanArgatroban
0781-3285ArgatrobanArgatroban
0781-3314ArgatrobanArgatroban
0781-9314ArgatrobanArgatroban
16729-430ARGATROBANArgatroban
25021-414ArgatrobanArgatroban
42023-182ArgatrobanArgatroban
42367-202ArgatrobanArgatroban
42367-203ArgatrobanArgatroban
55150-241ArgatrobanArgatroban
63323-526ArgatrobanArgatroban
68083-141ArgatrobanArgatroban
70121-1037ArgatrobanArgatroban
67457-212ArgatrobanArgatroban
65145-126ARGATROBANARGATROBAN

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.